Literature DB >> 8595695

Phosphatidylinositol responses are involved in the vascular effects of thiamylal and fentanyl.

O Shibata1, S Todoroki, Y Terao, S Goto, M Hirano, T Fujigaki, K Sumikawa.   

Abstract

Although thiobarbiturates potentiate, and fentanyl attenuates peripheral vasoconstriction, the intracellular mechanism involved in this phenomenon is not clear. Because smooth muscle contraction induced by alpha 1-adrenoceptor agonists is mediated by the phosphatidylinositol (PI) response, this study was carried out to clarify if thiamylal and fentanyl affect the norepinephrine-induced PI response in rat aortic slices. Rat aortic slices were incubated in Krebs-Henseleit solution containing 5 mM LiCl, [3H]myo-inositol, and varying concentrations of thiamylal or fentanyl. The Pl response was stimulated by 0.9 microM (ED50) norepinephrine (NE). The [3H]inositol monophosphate (IP1) was separated from [3H]myo-inositol by column chromatography and counted with a liquid scintillation counter. The basal IP1 accumulation was not affected by thiamylal and fentanyl. Norepinephrine-induced IP1 accumulation was potentiated by thiamylal at concentrations of 10 microM and 100 microM. Norepinephrine-induced IP1 accumulation was attenuated by 1 microM and 10 microM fentanyl. The results suggest that thiamylal stimulates the NE-induced PI response, which potentiates the vasoconstriction, and fentanyl attenuates NE-induced PI response, which would attenuate the vasoconstriction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8595695     DOI: 10.1007/BF03015106

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  23 in total

1.  Mechanism of arterial spasm following intra-arterial injection of thiopentone.

Authors:  J H BURN; R HOBBS
Journal:  Lancet       Date:  1959-05-30       Impact factor: 79.321

2.  High dose fentanyl anesthesia for coronary artery surgery: plasma fentanyl concentrations and influence of nitrous oxide on cardiovascular responses.

Authors:  J K Lunn; T H Stanley; J Eisele; L Webster; A Woodward
Journal:  Anesth Analg       Date:  1979 Sep-Oct       Impact factor: 5.108

3.  Anesthetic requirements and cardiovascular effects of fentanyl-oxygen and fentanyl-diazepam-oxygen anesthesia in man.

Authors:  T H Stanley; L R Webster
Journal:  Anesth Analg       Date:  1978 Jul-Aug       Impact factor: 5.108

4.  Stimulus-specific patterns of intracellular calcium levels in smooth muscle of ferret portal vein.

Authors:  J P Morgan; K G Morgan
Journal:  J Physiol       Date:  1984-06       Impact factor: 5.182

5.  Responses to barbiturates of isolated dog cerebral and mesenteric arteries contracted with KCl and prostaglandin F2 alpha.

Authors:  S Moriyama; K Nakamura; Y Hatano; T Harioka; K Mori
Journal:  Acta Anaesthesiol Scand       Date:  1990-10       Impact factor: 2.105

6.  Evidence that barbiturates inhibit antigen-induced responses through interactions with a GTP-binding protein in rat basophilic leukemia (RBL-2H3) cells.

Authors:  A J Robinson-White; S M Muldoon; L Elson; D M Collado-Escobar
Journal:  Anesthesiology       Date:  1990-06       Impact factor: 7.892

7.  Decrease in vascular resistance in the isolated canine hindlimb after graded doses of alfentanil, fentanyl, and sufentanil.

Authors:  D A White; J A Reitan; N D Kien; S J Thorup
Journal:  Anesth Analg       Date:  1990-07       Impact factor: 5.108

8.  Barbiturates inhibit endothelium-dependent and independent relaxations mediated by cyclic GMP.

Authors:  K Terasako; K Nakamura; H Toda; M Kakuyama; Y Hatano; K Mori
Journal:  Anesth Analg       Date:  1994-05       Impact factor: 5.108

9.  Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands.

Authors:  M J Berridge; C P Downes; M R Hanley
Journal:  Biochem J       Date:  1982-09-15       Impact factor: 3.857

10.  Histamine release during morphine and fentanyl anesthesia.

Authors:  C E Rosow; J Moss; D M Philbin; J J Savarese
Journal:  Anesthesiology       Date:  1982-02       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.